| |
|
|
| |
 |
 |
 |
 |
Contact Us
Please mail photos, text, audio cassette or video as applicable to |
PPH Cure Foundation
1735 Connecticut Ave., NW
3rd. Floor
Washington, DC 20009 |
 |
|
| |
|
|
|
|
United Therapeutics Corporation has commenced a 100+ patient study of Beraprost
(an oral version of prostacyclin) for pulmonary hypertension. The study is being
conducted by Dr. Richard Channick (UC San Diego) and others. The study lasts for
one year, during which a patient may be on active drug or placebo. In Japan, small
uncontrolled studies have led to Beraprost being approved for the treatment of primary
pulmonary hypertension.
|
|
|